Brain Scientific, Inc. · OTC:BRSF
Brain Scientific — Investor Presentation (November 2018)
25 slides from Brain Scientific's investor presentation, Nov 16, 2018
Slide 1: Investor Materials November 2018
Brain’ .. Scientific INVESTOR MATERIALS November, 2018 OTCPink: BRSF
Slide 2: Forward Looking Statements
ic FORWARD LOOKING STATEMENTS: THIS DOCUMENT IS PRIVATE AND CONFIDENTIAL, ‘CONTAINS SENSITIVE BUSINESS INFORMATION OF BRAIN, SCIENTIFIC INC. (‘BRAIN SCIENTIFIC’) AND IS NOT FOR PUBLIC DISTRIBUTION. This document has been prepared for informational purposes only andi provided personally te you, By ac
Slide 3: Company Overview
entific COMPANY OVERVIEW Brain Scientific is a New York City based healthcare technology company. Brain Scientific is catalyzing the next generation of telemedicine in neurology. On September 21, 2018, Brain Scientific Inc. (formerly known as All Soft Gels Inc.) completed its acquisition of MemoryMD
Slide 4: Teleneurology 2.0: Smart Diagnostic Device Enabled Teleneurology
"Eelentitic COMPANY OVERVIEW TELENEUROLOGY 2.0: “Smart” Diagnostic Device Enabled Teleneurology Portable, easy to use, clinical-grade (FDA cleared) remote diagnostic devices to allow use in teleneurology / remote settings. + Secure, cloud based, highly scalable infrastructure to transmit patient dia
Slide 5: The Problem: U.S. Neurologist Supply & Demand Mismatch
20 00 5000 7600 15000 THE PROBLEM U.S. Neurologist Supply & Demand Mismatch supply —— demo 16% growth in demand over 12 years t 19% Sota Brain Scientific is aiming to address the worsening gap in access to neurological care globally. Even within the US, a rapidly aging population with increased neur
Slide 6: The Problem: Uneven neurological expertise across regions
THE PROBLEM Furthermore, neurological expertise is soread unevenly across different regions. Several exist even in the US: 20 states in the US with less than
Slide 7: Market Size
MARKET SIZE Demand for broader access to neurological expertise is being met by the rapidly growing field of TELENEUROLOGY. ae Brain Global market for telemedicine technologies (all specialties including hardware, software and services). ~15% CAGR Teleneurology is the 4** largest category by market
Slide 8: EEG Market Problems
EEG MARKET PROBLEMS Current EEG gnostic systems Portable, light-weight, miniaturized equipment for Generally large, bulky equipment which is not suit- ease of use in every health-care environment able for fast-paced environments such as ERs and other settings (eg., remote diagnostics) Require a skil
Slide 9: Teleneurology Market's Problems / Key Impediments
TELENEUROLOGY MARKET'S PROBLEMS / KEY IMPEDIMENTS + Time consuming and complex to set up (e.g., EEG leads take ~30+ mins to set up). - Expensive (limiting availability in non-traditional settings). Teleneurology today is largely limited to video consults between remote physicians and neurologists. D
Slide 10: Market's Problem Conclusion
fic MARKET'S PROBLEM CONCLUSION Diagnostic tests such as EEGs are a mainstay of neurological care—and yet they cannot be easily conducted through teleneurology services today. Confidential 10
Slide 11: Solution
SOLUTION {eg,, ER, ICU, Com- munity Hospital in re- gions with low access to neurology) Disposable, easy to apply clinical-grade sensors. Portable, light- weight, blue-tooth enabled diagnostic device. Brain Scientific is taking teleneurology into the next generation by augmenting it with “smart” dia
Slide 12: Solution components
b: Disposable, easy to Portable, lightweight, Secure cloud for video Artificial Intelligence Teleneurology network apply clinical-grade blue-tooth enabled and diagnostic data powered analysis soft- of providers. sensors. diagnostic device. transfer and storage. ware for diagnostic in- terpretation a
Slide 13: Milestones: EEG Product Roadmap
eEelontitic MILESTONES. EEG Product Roadmap Our first substantial milestone in executing this vision is focused on EEG | 2018 FDA clearance for NeuroCap™ (22 Electrode, disposable EEG Headset) A 2019 2020 Devices for other diagnostic tests (e.g, EMG) developed First commercial contract signed for Ne
Slide 14: NeuroCap connects to any type of EEG amplifier
With the ability to connect to any type of EEG amplifier, NeuroC es setup and 5 minut fou a
Slide 15: NeuroCap Benefits
"elentitic NeuroCAP™ BENEFITS - Fixed Pre-Gelled Electrodes allow all clinical personnel to administer EEG. - Disposable Headset reduces patients exposure to infections eliminating the need to clean after each use. - Lightweight Plastic Material can be worn comfortably in clinical and home settings.
Slide 16: NeuroEEG
Slide 17: NeuroEEG Benefits
NeuroEEG™ BENEFITS «Mobile Amplifier can be quickly brought to where the patient is waiting. -Bluetooth Connectivity reduces artifacts from the movement of wires. " -FCC Certified Signal Quality proven to reduce electromagnetic interference across a range of clinical environments from home care to e
Slide 18: Milestones: Target Customer Segments
& Bane MILESTONES. TARGET CUSTOMER SEGMENTS Our target customer segments will broaden with the addition of key components to overall offering ae 2018 | 2019 | 2020 Tertiary Care Urban ERs/ ICUs Community / Rural ERs / ICUs Selling only NeuroCap into ERs / ICUs with existing EEG devices + neurologist
Slide 19: Business Model
BUSINESS MODEL 2018 | Volume based pricing A. Neuroceps™ 5. NeurozEo™ .Secure cloud D. Artificial inteligence enabled analysis software E-Teleneurologist Network { Razor-blade model Leasing of NeuroEEG™ sale of NeuroEEG™ with volume based pricing for NeuroCap™ Continuation of Razor- blade model desc
Slide 20: Financial Value Proposition
Financial Value Proposition to Physicians, Hospitals, and Testing Facilities CPT Reimbursement 95816 | Rout 1 | aE $427.78 95819 1 | e EG $491.57 EEG Tests Given 1 2 50 100, Revenue per Routine EEG $428 | $856} $21,400 $42,800 NeuroCap™ Works With lo} ie) @ (e) Your Existing Amplifier Disposable Cap
Slide 21: Go-to-Market Plan
Established Distributors Over the short-medium term, established medical device distributors will be leveraged for sales of the sensors (NeuroCap) + Neu- 1oEEG into hospital ERs / ICUs. International Distributors will be used in the me- dium term for EU and Asia Launch. GO-TO MARKET PLAN Enterprise
Slide 22: Partnership Opportunities
amazon aha) Recent moves by other industry giants are creating promi. partnership opportur for Brain Scienti to explore. @ CVS pharmacy” Walgreens OPPORTUNITIES od Brel i ic Opportunity for Brain Scientific to leverage Amazon's online distribution expertise to go-to-market in highly Opportunity for
Slide 23: Opportunities
OPPORTUNITIES The commercial pipeline for our current in-market products is robust and promising e One signed distributor — product launched in August, 2018 at a diagnostic conference. oe e Advanced discussions with large distributor covering Distributo ~4000 hospitals across the US. e Ongoing discu
Slide 24: Competition
COMPETITION elmiko Masimo- EGIL
Slide 25: Thank You!
THANK YOU!
Brain Scientific — Investor Presentation (November 2018) on 6ix